Table 1.
Consensus criteria items for the classification of pSS: | |
Abnormal unstimulated salivary flow rate* (⩽0.1 ml/min) | (1 point) |
Abnormal Schirmer’s test (<5 mm in 5 min) | (1 point) |
Abnormal findings with lissamine green or fluorescein staining | |
⩾5 in Ocular Staining Score or ⩾4 in Van Bijsterveld Score | (1 point) |
Presence of anti-Ro/SSA antibodies | (3 points) |
Histological evidence of focal lymphocytic sialadenitis,$ with a focus score ⩾1 focus/4 mm2 (1 focus = 50 lymphocytes/4 mm2) | (3 points) |
Diagnosis is considered established if score ⩾4 points, after application of inclusion and exclusion criteria | |
Inclusion criteria: | |
Dryness of eyes or mouth for at least 3 months, not explained otherwise (e.g. medications, infection) | |
Exclusion criteria: | |
Status post head/neck radiation | |
HIV/AIDS | |
Sarcoidosis | |
Active infection with hepatitis C virus (PCR replication rate) | |
Amyloidosis, graft versus host disease, IgG4-related disease | |
The lack of any other potentially associated disease is the key requirement for classification as pSS |
The patient is asked to sit still, not to speak or to chew for 5–15 min; the saliva produced during this time is transferred to a test tube and weighed.
Biopsy: removal of 3–5 labial minor salivary glands from the lower lip under local anaesthesia; fixation of biopsy material in formalin and HE staining.
ACR/EULAR, American College of Rheumatology/European League Against Rheumatism; AIDS, acquired immunodeficiency syndrome; HE, hematoxylin and eosin stain; HIV, human immunodeficiency virus; IgG, immunoglobulin G; PCR, polymerase chain reaction; pSS, primary Sjögren’s syndrome.